Hidalgo Nursing And Rehabilitation Center
Hidalgo Nursing and Rehabilitation Center in Edinburg, TX — inspection on April 29, 2026.
Found 2 citations. Severity: Standard violations.
Health inspections identify deficiencies that facilities must correct within required timeframes. Violations range from minor documentation issues to serious safety concerns and are subject to follow-up verification.
Inspection Findings
During an interview on 04/29/2026 at 05:00 pm, LVN B stated for antipsychotics, a consent was needed before the antipsychotic could be given and it could not be a verbal consent.
She stated the RP had to sign the consent. LVN B stated the negative outcome of not having a consent signed before administration could be the RP/family were not informed of side effects or they may not want them to give the medication.
During an interview on 04/29/2026 at 06:05 pm, the DON stated the nurses had already been in-serviced on appropriate forms for antipsychotics, appropriate indications for antipsychotics, and signed consents by the doctor/NP and the RP for any antipsychotic for a resident with Alzheimer's/dementia.
The DON agreed that Resident #1 had received Zyprexa on 04/01/2026 and 04/02/2026 without a consent form signed by the RP. A record review of the facility's policy Use of Psychotropic Medication(s), dated 03/05/2025, revealed, Policy Explanation and Compliance Guidelines: 9.Prior to initiating or increasing a psychotropic medication, the resident, family, and/or resident representative must be informed of the benefits, risks, and alternatives for the medication, including any black box warnings for antipsychotic medications, in advance of such initiation or increase. 10.
The resident has the right to accept or decline the initiation or increase of a psychotropic medication. 11.The facility will document that the resident or resident representative was informed in advance of the risks and benefits of the proposed care, the treatment alternatives or other options and the preferred option to accept or decline in a format the facility deems to use (e.g., written consent form, narrative note, etc.).
676346 04/29/2026
Hidalgo Nursing and Rehabilitation Center 4503 S Sugar Rd Edinburg, TX 78539
During an interview on 04/29/26 at 06:05 pm, the DON stated MH NP F had written the order for Zyprexa for Resident #1 with the indication of psychosis and a day or two later, they received paperwork from a facility that Resident #1 had had a diagnosis of Bipolar.
She said MH NP E had stated and wrote that Resident #1 had a history of schizophrenia, but she could not locate that diagnosis anywhere.
She said the nurses had already been in-serviced on appropriate forms for antipsychotics, appropriate indications for antipsychotics.
She said the new antipsychotics were reviewed at morning meetings.
Record review of the facility's Psychotropic Drug Use policy dated 03/05/2025 reflected: Policy: It is the intent of this policy to ensure that residents only receive psychotropic medications when other nonpharmacological interventions are clinically contraindicated.
Additionally, these medications should only be used to treat the resident's medical symptoms and not used for discipline or staff convenience which would deem it a chemical restraint. of this facility to ensure that residents who have not used psychotropic drugs are not given these drugs unless the medication is necessary to treat a specific condition as diagnosed and documented in the clinical record.
Definitions Chemical restraint refers to any drug used for discipline or makes it more convenient (i.e., less effort) for staff to care for a resident, and not required to treat medical symptoms.
This includes instances when a psychotropic medication may be approved to treat certain symptoms, however, nonpharmacological interventions should be used or attempted, unless clinically contraindicated because they are less dangerous to a resident's health and safety.
Policy Explanation and Compliance Guidelines:1.A psychotropic drug is any drug that affects brain activities associated with mental processes and behavior.
Psychotropic drugs include, but are not limited to the following categories: antipsychotics, antidepressants, anti-anxiety, and hypnotics. 2.Psychotropic medications are to be used only when a practitioner determines that the medication(s) is appropriate to treat a resident's specific, diagnosed, and documented condition and the medication(s) is beneficial to the resident, as demonstrated by monitoring and documentation of the resident's response to the medication(s).
Frequently Asked Questions
More Reports
Source: This inspection report was downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases nursing home inspection reports in bulk. The findings reflect what state surveyors documented in the official Form CMS-2567 Statement of Deficiencies on the date of the inspection.
Plan of correction not included: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to their state survey agency and those responses may not appear in CMS public data at the time of release. The absence of a plan of correction in this report does not mean one was not filed. Readers who want information about corrective steps taken by the facility are encouraged to contact the facility or their state survey agency directly.
Corrections may have been made: This report reflects conditions observed on the date of the survey. The facility may have implemented staffing changes, additional training, policy revisions, or other corrective actions since this report was issued. We publish what CMS provides and encourage readers to seek current information from the facility.